SUMMARY.-In vivo metabolic studies on rats and mice revealed a marked difference in the fluorescent compounds produced after ingestion of aflatoxin B1. The mouse converted aflatoxin B1 to three unknown fluorescent compounds, designated xl, x2 and x3 and the known aflatoxin M1, while the rat was only capable of producing aflatoxin M1. The results suggested that metabolites X1, X2, x3 and aflatoxin M1 were not part of a major metabolic pathway, but produced independently. These unknown yellowish-green fluorescent compounds did not seem to be conjugated with sulphate or glucuronic acid.
MATERIALS AND METHODS
All chemicals used were of analytical reagent grade. Nicotinamide-adenine dinucleotide phosphate, reduced form (NADPH) was obtained from Boerhinger, West Germany. Protein concentrations were determined as described by Lowry et al. (1951) . ,8-glucoronidase (bovine-liver) and aryl sulphatase (Helix pomatia) were obtained from Calbiochem., Switzerland. 14C-Carboxyl-labelled acetate (specific activity 25 Ci/mole) was obtained from The Radiochemical Centre, Amersham, and used to synthesize 14C-uniformly labelled aflatoxin B1 according to the method of Adye and Mateles (1964) and purified as described by Steyn (1970) . In vivo studies Aflatoxin B1 metabolism in mice and rats.-Two male rats (average weight 220 g.), and eight adult male mice (mean weight 23 + 2 g.) were dosed per o8 with aflatoxin B1 (10 mg./kg.) in dimethylsulphoxide (DMSO) (0.1 ml.) and killed with ether 2 hours later. Their livers, kidneys, stomachs plus intestines and bladders plus urine were excised, weighed and extracted according to Purchase and Steyn (1969) , utilising an azeotrope consisting of acetone: chloroform: water (58: 38: 4). The concentration of aflatoxin B1 was assayed according to Pons, Robertson and Goldblatt (1966) .
Absorption of aftatoxin Blfrom the stomachs of mnice.-Twelve male mice (average weight 23 g.) were each dosed per os with aflatoxin B1 (10 mg./kg.) in DMSO (0-1 ml.). Two mice were killed with ether at 2, 1, 2, 4, 6 and 71 hours after 2'2 dosing and their stomachs and intestines removed. These organs were assayed for aflatoxin B1 as described above.
Rate of aflatoxin B1 metabolite formation in mice.-Twelve male and 12 female mice (average weight 23 ± 2 g.) each received an oral dose of 3*0 mg. aflatoxin B in 0*1 ml. DMSO. Two males and two females were killed as before at 20, 40, 70, 100, 150 and 180 minutes after dosing. Their livers, stomachs plus intestines, kidneys and bladders plus urine were removed and treated as above. The relative amounts of the unknown metabolites are expressed in jtg. aflatoxin B1 equivalents as no quantitative standards of the unknown were available.
Two male mice (± 23 g.) each received an oral dose of 3 mg. 14C aflatoxin B1 (30 x 103 d.p.m./mg. aflatoxin) in 0-1 ml. DMSO and were killed after 100 minutes as described before. Urine was collected from the bladders by means of a 1 ml. syringe (total volume of urine, 0 7 ml.) and chromatographed on 1 mm. thin-layer chromatography (t.l.c.) plates. The fluorescent bands, containing metabolites xl, x2 and aflatoxin M1, were separately collected and the radioactivity measured in a Beckman liquid scintillation system.
In vitro studies
Preparation of liver cell fractions.-Two adult male mice were decapitated, their livers (total weight 6 g.) removed and homogenized in 18 ml. 0-32M sucrose3mM MgCl2-0.02M TRIS buffer, pH 7-6, in a Dounce homogenizer. The suspension was centrifuged in an MSE-mistral 2 L centrifuge at 1800 g for 20 minutes to remove the nuclei, which were discarded. The supernatant was then centrifuged at 9000 g for 20 minutes in a Spinco L-4 ultracentrifuge, to yield the crude mitochrondrial fraction, which was suspended in 10 ml. 0-02M TRIS buffer, pH 7.4, and kept. The microsomes were obtained by centrifugation of the resultant supernate at 105,000 g for 60 minutes, washed twice with 10 ml. of the above mentioned buffer and diluted with the same buffer to a protein concentration of 10-15 mg. per ml. The supernatant, which consisted of the soluble cell fraction, was used undiluted.
Incubation of aftatoxin B1 with different cellfractions.-The incubation mixtures, with a final volume of 5 ml., were made up as follows:
1. Aflatoxin B1 in methanol or 1,2-propylene glycol (7 mg./ml., 0 4 ml.); 2. 0*02M TRIS buffer, pH 7-4 (3.4 ml.); 3. MgCl2 solution (14.2 g./L, 0-2 ml.); 4. NADPH (74.5 mg./l ml. TRIS buffer solution): 0 5 ml.; 5. Cell fraction: 0.5 ml. All incubations were carried out in a shaking water bath at 370 C. in cotton wool plugged test tubes for 30 to 60 minutes. The reactions were terminated by the addition of 10 ml. acetone. Reaction mixtures were transferred quantitatively to suitable flasks by washing with two more 10 ml. portions of acetone.
Conjugates.-Enzyme incubations were performed as described by Fishman (1946) and Whitehead et al. (1952) , after addition of chromatographically pure x1, x2 and x3. These metabolites were also boiled in 6N HCl for 5 minutes (Oser, 1965) .
Chromatographic methods All extracts were evaporated to dryness in a rotary evaporator (under reduced pressure) at 450 C., and dissolved in 2 ml. benzene : acetonitrile (95 : 5). T.l.c. plates were prepared from Camag D-5 silica gel (Camag, Switzerland), wet layer thickness 0 5 mm., heated at 1000 C. for 2 hours and cooled at room temperature immediately before use. After application of suitable quantities of extracts, as well as a quantitative aflatoxin B1 standard, the chromatograms were developed in an unlined tank containing 100 ml. chloroform : acetone (80 : 20) as the mobile phase.
The following procedures were used to identify aflatoxin M1 in several mouse organs:
1. T.l.c. employing four different mobile phases, namely, chloroform : acetone (80 : 20); chloroform : methanol (95: 5); trichlorethylene acetone (10 90), and benzene ethanol : water (46: 45: 19). 2. Paper chromatography, as described by Holzapfel et al. (1966) . 3. Ultra-violet spectrophotometry, employing a Beckman model DK-2A spectrophotometer.
RESULTS

In vivo experiments
Metabolismn of aflatoxin B1 by the mouse.- Fig. 1 illustrates the typical metabolic conversion pattern of aflatoxin B1 by various organs of the mouse and Fig. 2 demonstrates the difference in metabolism of aflatoxin B1 between rat and mouse livers. From Fig. 1 and 2 it is clear that only the mouse is able to metabolize aflatoxin B1 to three unknown fluorescent metabolites, two major and one minor, designated xl, x2 and x3, respectively. These compounds all fluoresce green-yellowish. The 4th blue fluorescent metabolite with an Rf value between that of xi and x2 was shown to be chromatographically identical to aflatoxin M1 and to have a similar ultra-violet spectrum. The rate of production of xl, x2 and aflatoxin M1 from combined organ extracts, expressed in ,ug. aflatoxin B1 equivalents, is shown in Fig. 3 .
From Table I it is evident that metabolites x1, x2 and aflatoxin M1 recovered from the urine of mice dosed with 14C-aflatoxin B1 are radioactive. Metabolite No fluorescent substances resembling B1 or its metabolites were observed in extracts from control animals.
The ability of the mouse to absorb consistently more aflatoxin B1 from its stomach than the rat, is illustrated in Fig. 4 . 
In vitro experiments
Conversion of aflatoxin B1 by Mouse liver cellfractions.-The ability ofthe various fractions to metabolize aflatoxin B1 is illustrated in Fig. 5 , which distinctly indicates that only the microsomal fraction is capable of producing a variety of fluorescent metabolites. Furthermore, it is also clear that the conversion mechanism, present in the microsomal fraction, needs NADPH (Fig. 5) . Assay for conjugates.-Treatment of chromatographically pure xl, x2 and X3
with ,3-glucuronidase (bovine liver) aryl sulphatase (Helix pomatia) or 6N HC1 showed no effect. 
DISCUSSION
When a comparison is made between the amount of aflatoxin B1 in rat and mouse stomachs after a single dose, it is clear that the mouse absorbs the toxin more quickly than the rat. As the acute toxicity in the mouse and rat are approximately the same, the mouse must either be more resistant to the effects of the toxin per se or it must be able to metabolize (detoxify) the toxin at a greater rate than the rat. The ability of the mouse to produce numerous fluorescent metabolites, and the absence of large quantities of aflatoxin B1 in liver and kidneys indicate that the mouse is capable of metabolizing aflatoxin efficiently.
The absence of carcinogenicity of aflatoxin in mice may also be related to the rapid metabolism. Alternatively, if aflatoxin B1 is converted into an " ultimate " carcinogen by metabolism in the rat, the lack of carcinogenicity could be due to the different metabolic conversion products produced by the mouse. Further studies on the identity and biological activity of aflatoxin metabolites may indicate which of these two suggestions is correct.
The in vitro experiments clearly indicate that only the microsomal fraction of mouse liver contains the enzyme(s) necessary for the conversion of aflatoxin B1
to M1 and the other three fluorescent components. In addition, it is also possible that the cytochrome P-450 component, which is the rate-limiting step in drug conversion of mouse liver microsomes, has a higher affinity for aflatoxin B1 than that of the rat. Since we accept the observation that the mouse is resistant to aflatoxin B1-induced carcinogenicity, the conversion of aflatoxin B1 to the three fluorescent compounds could be used as a monitoring system to study the susceptibility of various animal species, including man, to aflatoxin B1-inducible carcinogenesis. Obviously, much more work has still to be done to validate such a statement.
Although highly unlikely, the possibility existed that the metabolites xl, x2 and aflatoxin M1 were formed in mice through the synergistic action of aflatoxin B1 and DMSO from some other compound normally present in the animals. This possibility was exluded by using 14C-aflatoxin B1 (Table I) .
Whether aflatoxin M1, metabolites xl, x2 and x3 are minor metabolites or intermediates in a major metabolic pathway in the mouse cannot be deduced from our results. However, the results in Fig. 3 suggest that these metabolites are synthesized independently, since their excreted concentrations are similar at any particular time. Both mouse and rat livers could also metabolize aflatoxin B1 to non-fluorescent compounds which are not perceptible, or to fluorescent metabolites which are not extracted with the acetone: chloroform: water azeotrope.
It also seems that xl, x2 and X3 are not glucuronide or sulphate conjugates.
The results of this study clearly demonstrate that the mouse can hydroxylate aflatoxin B1 to aflatoxin M1. This is in agreement with the results from Portman et al. (1968) who suggested that mouse liver microsomes hydroxylate aflatoxin B1 (forming M1) faster than those of rat liver. However, these authors did not mention the presence of other fluorescent components. Although Bassir and Emafo (1970) failed to demonstrate M1 production by mouse liver, they did describe the presence of a green-yellow fluorescent substance. Whether their unknown fluorescent compound corresponds with our xl, x2 or X3 is at present unknown. These differences could be due to different strains of mice or to different extraction techniques used by the various authors.
